Xcout Intel
BRISTOL-MYERS SQ
Bristol Myers Squibb is a global biopharmaceutical company that researches, develops, and delivers innovative medicines to help patients prevail over serious diseases. The company focuses on therapeutic areas including oncology, hematology, neuroscience, immunology, and cardiovascular research.
Subscribe to see BRISTOL-MYERS SQ’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
BRISTOL-MYERS SQ competitors
A few of BRISTOL-MYERS SQ's closest competitors — see the full list of competitors and alternatives →
Johnson & Johnson researches, develops, and delivers innovative medicines, therapies, and medical technology devices. The company focuses on healthcare areas such as oncology, neuroscience, immunology, cardiovascular diseases, orthopaedics, and surgery to serve patients globally.
Novartis is a global healthcare company that researches, develops, and manufactures innovative medicines across therapeutic areas such as oncology, immunology, neuroscience, and cardiovascular diseases. The company serves patients, healthcare professionals, and healthcare systems worldwide by providing pharmaceutical treatments and managing clinical trials.
GSK is a biopharmaceutical company that discovers, develops, and delivers medicines and vaccines for patients globally. Its research and development efforts focus on four primary therapeutic areas: respiratory, immunology and inflammation, oncology, HIV, and infectious diseases.
Sanofi is a research-driven, artificial intelligence-powered biopharmaceutical company that develops and manufactures innovative medicines and vaccines. It serves patients globally across multiple therapeutic areas, including immunology, neurology, oncology, rare diseases, and general medicines.
Ipsen is a global biopharmaceutical company that researches, develops, and commercializes innovative medicines. It primarily serves patients suffering from conditions in the fields of oncology, rare diseases, and neuroscience.
UCB is a global biopharmaceutical company that researches, develops, and delivers medicines and solutions for patients living with severe neurological and autoimmune conditions. It serves individuals with chronic and rare diseases as well as healthcare professionals through treatments, clinical studies, and support services.
Get BRISTOL-MYERS SQ's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on BRISTOL-MYERS SQ in Xcout Intel
- The full competitor set, tracking, exports and API access